NCT02926131

Brief Summary

This is an observational prospective study. The main purpose is to evaluate the stability of the Bilistick system in a humid and hot climate compared to the quantitative test for serum bilirubin (SBR) measurement currently used, the BR-501 total bilirubin meter, kept in a controlled environment. The secondary aim is to assess the operational feasibility of the Bilistick system in a tropical limited-resource setting, when used by locally trained nurses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 6, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

January 25, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2017

Completed
Last Updated

October 2, 2018

Status Verified

July 1, 2018

Enrollment Period

11 months

First QC Date

September 22, 2016

Last Update Submit

October 1, 2018

Conditions

Keywords

stick test

Outcome Measures

Primary Outcomes (2)

  • Comparison of the agreement of serum bilirubin measurement between the two tests in three different seasons

    The main outcome of interest is the potential effect of environmental conditions on the quantitative outcome of the Bilistick System, using BR-501 bilirubin meter machine as a reference. The Bland-Altman analysis will be used to compare the two tests.

    18 months

  • Within each season, evaluation of the impact of temporal variation on the agreement of serum bilirubin measurement between the two tests.

    A linear regression analysis will be done to look for statistically significant effect of exposure time on the difference between the average total bilirubin serum levels of the two tests.

    18 months

Secondary Outcomes (2)

  • Evaluation of the usability of the Bilistick system using a 5-point likert scale questionnaire and a focus group discussions

    18 months

  • Perception by the trained nurses of the Bilistick system usability with a focus group discussion (FGD).

    18 months

Study Arms (1)

Infants

Infants requiring serum bilirubin (SBR) measurement seen in Wang Pha clinic (WPA) clinic.

Other: Blood sampling

Interventions

* One full capillary tube (50µl blood) will be used to measure the Hct level and the routine SBR using the BR-501 bilirubin meter machine (non-study procedure). * An additional half- filled capillary tube (25µl blood) will be used for the SBR measurement with the Bilistick system

Infants

Eligibility Criteria

Age1 Day - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infant seen in WPA clinic during the neonatal period (birth to 28 days of life).

You may qualify if:

  • Written or thumb print for informed consent from the parent
  • Infant born ≥ 35 weeks of gestational age
  • Infant who needs a routine SBR measurement
  • Infant in stable clinical condition prior to SBR measurement confirmed by the trained nurses

You may not qualify if:

  • The participant will not be enrolled in the study if ANY of the following applies:
  • Infant who already had 1 SBR measurement done with the Bilistick system
  • Last haematocrit measurement \> 65% or no previous haematocrit measurement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shoklo Malaria Research Unit (SMRU)

Mae Sot, Changwat Tak, 63110, Thailand

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood

MeSH Terms

Conditions

Jaundice

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

HyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and SymptomsSkin ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Professor Rose McGready, MD

    Shoklo Malaria Research Unit (SMRU)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2016

First Posted

October 6, 2016

Study Start

January 25, 2017

Primary Completion

December 11, 2017

Study Completion

December 11, 2017

Last Updated

October 2, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations